Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available
Pre-emptive pharmacogenomic (PGx) testing of a panel of genes may be easier to implement and more cost-effective than reactive pharmacogenomic testing if a sufficient number of medications are covered by a single test and future medication exposure can be anticipated. We analysed the incidence of ex...
| Main Authors: | , , , , , , , , |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
PUBLIC LIBRARY SCIENCE
2016
|
| Online Access: | http://hdl.handle.net/10150/621819 http://arizona.openrepository.com/arizona/handle/10150/621819 |